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Abstract
Background: A selective chiral high-performance liquid chromatography (HPLC) method was developed and
validated to separate and quantify the (d) and (l) carbinoxamine enantiomers in human plasma.
Methods: Plasma samples were extracted by liquid-liquid extraction. The separation of carbinoxamine enantiomers
and internal standard (IS, pargeverine hydrochloride) was achieved on an amylose tris(5-chloro-2-methylphenylcarbamate)
column with a mobile phase of n-Hexane/isopropanol/ethanol/diethyl amine (850:75:75:0.1, v/v/v/v) at a flow rate of
0.8 mL/min. The ultraviolet (UV) detection wavelength was set at 220 nm.
Results: Baseline separation of carbinoxamine enantiomers and IS, free from endogenous interferences, was achieved in
less than 15 min. Ratio of peak area of each enantiomer to IS was used for quantification of plasma samples. Linear
calibration curves were obtained over the range of 20–7500 g/mL in plasma for both enantiomers (R2 > 0.99). The mean
extraction recoveries were 103.8 ± 1.5 and 94.5 ± 1.8 % for (d) and (l) enantiomers of carbinoxamine enantiomers and
96.35 % for IS from human plasma. The mean relative error (RE %) of accuracy and the mean relative standard deviation
(RSD %) of intra-day and inter-day precision for both enantiomers were <10 %.
Conclusions: The method was validated with accuracy, precision, recovery, and stability and can be used to determine
the pharmacokinetics of carbinoxamine enantiomers in human plasma.
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Background
In the pharmaceutical industry, enantiomeric separation
has become an important area of study as the single-
enantiomer drugs are found to be safer than racemic
drugs (Pharma Book 2009). Carbinoxamine (CA) is an
oral antihistamine agent that acts primarily by compet-
ing with the histamine in binding to H1 receptor. It is
used as monotherapy or in combination with pseudo-
ephedrine (or) paracetamol in the management of hay
fever and allergic conjunctivitis. It is also has anticholin-
ergic properties, and because of which, it is used in the
treatment of Parkinson’s disease. The chemical structure
of CA was shown in Fig. 1, with one chiral center at-
tached with pyridyl ring and chlorphenyl ring. It is
commercially available as the maleic acid salt (River’s
Edge 2011). Investigations have shown that CA was used
as the racemic mixture clinically.
Ethanolamine class of H1 antihistamines were proven
to show stereoselectivity in binding to the receptors
(Casy et al. 1992). Doxylamine which is a similar kind of
molecule to that of carbinoxamine showed that its (d) or
(+) form has more binding affinity compared to its anti-
pode (Tadiboyina et al. 2015). It is currently unclear
whether CA enantiomers also possess different pharmaco-
dynamics, toxicological, or pharmacokinetic properties.
To determine the pharmacokinetic properties of CA enan-
tiomers in vivo, it is necessary to establish a reliable
method for the detection of CA enantiomers in biological
samples. Table 1 shows some methods for determination
of racemic CA in biological fluids and dosage forms. So* Correspondence: tadiboyina.sirisha@gmail.com
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far, very few studies were carried out to separate carbinox-
amine into its individual enantiomers. Yi-Fen et al. (2000)
developed a quantitative chiral analysis of carbinoxamine,
doxylamine, and orphenadrine by capillary zone elec-
trophoresis, but the method is not validated and not
applied for bio-analytical studies. Therefore, it is unknown
whether this method provides sufficient sensitivity and
selectivity for bio-analytical studies. To our knowledge,
no enantioselective methods have been developed for the
determination of CA enantiomers in biological samples
using a polysaccharide-based chiral column. In this paper,
we describe the development of a stereoselective method
for CA in the presence of internal standard pargeverine
hydrochloride (PGV) (Fig. 2) by the normal phase method.
Stationary phase was selected on the basis of functional
groups present in the compound; mobile phase compos-
ition was systemically studied and finally optimized the
method conditions by using eco-friendly solvents.
Fig. 1 Chemical structure of carbinoxamine maleate
Table 1 Methods for the determination of CA in biological fluids and dosage forms
Method Conditions Detection system Matrices References
LC-MS/MS BDS Hypersil C8 (100 × 4.6) column;
mobile phase: acetonitrile:buffer (80:20 v/v);




Human plasma (GeetaBhavani et al. 2014)







Human plasma (Michael et al. 2008)
Ion exchange
chromatography





(Ramadan and Mandil 2006)
Spectrophotometry
and HPLC
ACE C18 (250 × 4.6 mm) column; mobile






(Ismail and Feyyaz 2012)
Acetonitrile, 0.01 sodium perchlorate (pH 3)
DPP and DCP Mobile phase: phosphate buffer (pH 1.69) using












C18 (300 × 3.9 mm); mobile phase: methanol:
monobasic phosphate buffer (60:40 v/v) with






(de Carina and Marcone 2009)




Bulk drug (USP29-NF24 2007)
Capillary zone
electrophoresis
Pre-column dervetization using sulfated
beta-cyclodextrin as a chiral selector; mobile
phase: tris buffer (100 mM pH 4.6)
UV detection
200 nm (anode at
detection side)
Bulk drug (Yi-Fen et al. 2000)
HPLC Amylose-based chiral column (250 × 4.6 mm);
mobile phase: hexane:ethanol (90:10 v/v)
UV detection
220 nm (22 °C)
Bulk drug (Phenomenex 2013)
DPP differenetial pulse polarography, DCP differential current polarography
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Methods
Chemicals and materials
Carbinoxamine maleate and pargeverine hydrochloride
standards were gifted by RL Fine Chemicals, Bengaluru,
India. n-Hexane, 2-proponol, ethanol, and diethylamine
were procured from Merck, Mumbai, India. High-
performance liquid chromatography (HPLC)-grade water
was obtained from a Milli-Q unit (Millipore, Milford,
USA). Blank human plasma was obtained from JSS Medical
College and Hospital, JSS University, Mysuru, India.
Instrumentation
The instrumentation consisted of a Shimadzu Promin-
ence LC-20 AD ultrafast liquid chromatography (UFLC)
equipped with a 1260 binary pump VL (35 MPa), Prom-
inence SIL-20ACHT Auto sampler, and Prominence
SPD-M20A Diode array detector. All weighings for ana-
lysis were performed on a Shimadzu electronic analytical
balance AY-220 (Shimadzu). Plasma samples were soni-
cated on a Mark ultrasonic sonicator and vertexed on a
Remi cyclomixer; centrifugation was done using REMI
centrifuge model number 412 LAG (REMI Instruments
Division, Vasai, India). Water used for analysis was pre-
pared from Millipak Express 20 filter unit. Microsoft
Excel 2007 was used for analysis of validation results.
Chromatographic conditions
The chromatographic separations were carried out on
amylose tris(5-chloro-2-methylphenylcarbamate) column.
The mobile phase was a mixture of n-Hexane/isopropa-
nolthanol/diethyl amine (850:75:75:0.1, v/v/v/v) with
0.8 mL/min of flow rate, and detection was performed by
a photodiode array detector (PDA) at 220 nm.
Preparation of stock and standard solutions
Stock solutions of CA and PGV in isopropanol were
prepared separately at a concentration of 10 μg/mL. A
series of standard mixture solutions were prepared by
the appropriate dilution of the stock standard solutions
with isopropanol to a concentration range of 0.4–
1000 μg/mL for CA and 40 μg/mL for PGV.
Preparation of samples
The plasma samples were thawed at room temperature.
The samples were vortexed adequately before pipetting.
To a 200-μL aliquot of plasma, 100 μL of racemic CA
stock solution (0.4–1000 μg/mL), 100 μL of IS solution
(40 μg/mL), and 100 μL of 1 M NaOH were added and
vortexed for 1 min in a 2-mL Eppendorf tube. The
mixed samples were then extracted with 1.5 mL of di-
chloromethane: n-Hexane (1:2), by vortex mixing for
2 min. After centrifugation at 5000 rpm for 15 min,
1.0 mL of the upper organic layer was transferred to
another tube. Extracts were concentrated to dryness
at the 40 °C under a gentle stream of nitrogen and
reconstituted with 150 μL of ethanol. A 25-μL aliquot




The plasma calibration curve was constructed using a
blank sample (matrix sample processed without analyte or
internal standard), a zero sample (matrix sample proc-
essed without analyte but with internal standard), and six
non-zero samples (matrix samples processed with analyte
and internal standard) covering the expected range includ-
ing lower limit of quantification (LLOQ), 20–7500 ng/mL
with 2000 ng/mL of IS concentration.
Extraction recovery
The efficiency of carbinoxamine enantiomers and IS
extraction from human plasma was determined by com-
paring the responses of the analyte extracted from six
reproduce QC samples with the response of analyte
from neat standards at equivalent concentrations by a li-
quid-liquid extraction process. Recoveries of CA were de-
termined at the LLOQ, QC low, QC medium, and QC
high concentrations that is, 20, 300, 1200, and 5000 ng/
mL. Whereas the recovery of the IS was determined at a
single concentration of 2000 ng/mL.
Accuracy and precision
The intra-assay accuracy and precision were estimated
by analyzing six replicates containing CA at four differ-
ent QC levels, that is, 20, 300, 1200, and 5000 ng/mL.
The inter-assay precision was estimated by studying the
quality control samples on four different runs. The cri-
teria for acceptability of accuracy data within 85–115 %
of the actual values and ±15 % relative standard devi-
ation (RSD) except for LLOQ for precision.
Fig. 2 Chemical structure of the internal standard pargeverine
hydrochloride
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Fig. 3 Effect of organic modifiers on the resolution of CA enantiomers a methanol, b ethanol, c isopropanol, d n-butanol, e ethanol:isopropanol (1:1)
Table 2 Screening of alcoholic modifiers
Trail no. Alcoholic modifiers Alcoholic modifier (×) per
100 mL of mobile phase (mL)
Observations
1 Methanol 15 Poor resolution between the enantiomers, tailing of peaks observed
2 Ethanol 15 Enantiomers eluted very lately and the peak shape is broad.
3 Isopropanol 15 Enantiomers eluted early but not separated completely; no resolution between the peaks.
4 n-Butanol 15 No proper separation of enantiomers
5 Ethanol:isoproponol 7.5:.5 Enantiomers eluted early with good resolution and capacity factor.
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Stability experiments
Stability tests were conducted to evaluate the stability of
CA enantiomers in plasma samples under different con-
ditions. In-injector stability (24 h), bench-top stability
(12 h), freeze-thaw stability (3 cycles), and freezer stability
(80 ± 10° C for 25 days) were tested at LQC (300 ng/mL)
and HQC (5000 ng/mL) levels using six replicates at each
level. Samples were said to be stable if assay values were
within the acceptable limits (i.e., 85–115 % accuracy and
±15 % RSD from fresh samples).
Results and discussion
Method development and optimization
Selection of chiral stationary phase
The finest chiral stationary phases (CSP) for the separation
of aromatic compounds with functional groups such as
carbonyl, alcohol, and amine (like carbinoxamine) are
amylose-based polysaccharide stationary phases (LCGC
2008). Immobilized polysaccharide columns are compatible
with a wide range of solvents; hence, they can be operated
in both reverse phase and normal phase which increased
the range of applications (Othman et al. 2012). Hence, the
coated amylose-based polysaccharide column was selected
for screening.
The CSP is amylose tris(5-chloro-2-methylphenylcarba-
mate) bonded to silica gel. The separation of enantiomers
may be attributed to hydrogen bonding interactions
between the amine group of solute and the hydrophilic
carbamate group on the CSP. Steadying effect on the
solute-CSP complex will be there for the solutes having
aromatic functional groups (Irving and Rose 1987). This
type of steadying effect (or) stabilization effect may also
exist in CA owing to the presence of aromaticity.
Selection and optimization of additives
As polysaccharide-based CSPs generally show a higher
success rate in resolving enantiomers under normal-
phase elution (Brian 2010); hence, this mode was ex-
plored first. The selection of mobile phases was initiated
with traditional alkane/alcohol mixtures (Chiral Tech-
nologies 2004). n-Hexane was given first preference as it
is comparatively green (Paul et al. 2012). For separation
of most of the analytes containing basic and/or acidic
functional groups, the additive plays a major role in in-
creasing the chromatographic efficiency (Zhang et al.
2012). The additives were used in the present word in














4.9 3784 1.12 – –
(d)-form 5.8 5387 1.38 3.95 1.15
(l)-form 6.79 5821 1.32 3.01 1.28
Fig. 4 Spectra Comparison of both the (d) and (l) CA enantiomers obtained from photodiode array detector
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order to improve the peak shape. All chromatographic
parameters were kept constant (flow rate, 0.8 mL/min,
ambient column oven temperature; injection volume,
25 μL; wavelength, 220 nm) except the % additive added.
Diethylamine and triethylamine were often used as a
modifier for basic drugs with amine groups to ensure
elution from the column and to obtain good peak shape
(Toussaint et al. 2000). Hence 0.01 % diethylamine was
Fig. 5 HPLC chromatograms of a 25 μL injection containing pargeverine hydrochloride (I), (d)-form (II) and (l)-form (III) in a human blank plasma,
b blank human plasma spiked with IS (zero sample), and c blank human plasma spiked with CA and IS (non-zero sample)
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introduced into the mobile phase, CA enantiomers were
eluted at around 10 min, and the peaks were highly
asymmetric. Further increase in diethylamine content
(0.1 %) has significant impact on the peak shape,
whereas the mobile phase without diethylamine signifi-
cantly distorted the peak shape.
Selection of alcoholic modifiers
In chiral separations, the alcohols play a major role in
creating a selectivity difference (Tang 1996). Hence, the
ratio of the mobile phase components n-Hexane/alco-
hol/diethylamine was fixed at 85:15:0.01 (v/v/v) and the
effect of different alcohols on selectivity was studied
(Fig. 3). The details of different alcohols screened (trials
1–5) and their results are given in Table 2. The results
of trials 3 and 4 appeared to be complementary. Ethanol
alone as an alcoholic component in trial 2 produces
broad peaks with slow elution. Isopropanol alone eluted
the enantiomers very early, and because of which, the
resolution is not proper. Hence, to achieve the comple-
mentary effects of trials 2 and 3, ethanol and isopropa-
nol was tested together (trial 5). Since trial 5 showed a
significant improvement in the retention and resolution,
an equal ratio of ethanol and isopropanol were used for
the analysis. Hence, at the optimized chromatographic
conditions, the internal standard and the enantiomers
were eluted at 4.9, 5.8, and 6.79 min, respectively, pass-
ing all the chromatographic parameters (Table 3).
Optical rotation of CA enantiomers
The order of elution of (‘d’) or (+) and (‘l’) or (−) CA
enantiomers was determined by collecting eluent frac-
tions from repeated injections (Dalia et al. 2008).
There were ~45 injections made into the UFLC, with
150 μg racemate per injection. Figure 4 depicts the
spectral comparison of both the enantiomers, which
shows that both the peaks represent the same drug.
After compiling the eluent fractions corresponding to
each enantiomer, they were dried by passing the ni-
trogen gas and reconstituted in methanol and the op-
tical rotation was determined using a Jasco P-2000
(JASCO Analytical instruments, USA).
Assay validation
The bio-analytical validation was performed according
to FDA guidelines (FDA guideline 2001).
Calibration curve
The calibration standard curve had a reliable reprodu-
cibility over the standard concentrations across the
calibration range. The calibration curve was con-
structed by determining the best fit of peak area ratios
(peak area analyte/peak area IS) vs. concentration and
fitted to the y =mx + c. The average regression (n = 3)
was found to be ≥0.996 for both the (d) and (l) enantio-
mers of CA. The lowest concentration with the RSD
<20 % was taken as the LLOQ and was found to be
20 ng/mL.
Extraction recovery
One-step liquid-liquid extraction technique gave ad-
equate recovery and cleaner samples (Fig. 5). The results
of the comparison of neat standards vs. human plasma-
extracted standards were estimated for CA enantiomers
at low (300 ng/mL), medium (1200 ng/mL), and high
Table 5 Intra- and inter-day precision of determination of CA in human plasma
Theoretical concentration
(ng/mL)
Measured concentration (ng/mL), (n = 6)
Mean ± SD RSD Accuracy (%)
(d)-form (l)-form (d)-form (l)-form (d)-form (l)-form
Intra-day variation
20 20.1 ± 0.85 19.4 ± 0.35 4.2 1.8 102 97
300 320 ± 5.28 307 ± 6.35 1.65 2.06 107 102
1200 1228 ± 10.4 1261 ± 9.37 0.84 0.74 102 105
5000 4734 ± 24.5 4675 ± 20.15 0.51 0.43 95 94
Inter-day variation
20 20.5 ± 0.17 20.6 ± 0.74 0.82 3.5 103 103
300 314 ± 2.38 324 ± 7.12 0.75 2.19 105 108
1200 1274 ± 11.3 1257 ± 18.74 0.88 1.49 106 105
5000 4735 ± 70.1 4823 ± 88.45 1.48 1.83 95 96
Table 4 Recovery of Carbinoxamine enantiomers (n = 6)
Mean recovery % ± SD
Quality control sample (ng/mL) (l)-carbinoxamine (d)-carbinoxamine
LQC ± 300 103.1 ± 2 101.7 ± 7.60
MQC ± 1200 94.4 ± 3 104.5 ± 2.7
HQC ± 5000 97.4 ± 6 94.1 ± 8.9
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(5000 ng/mL) levels, and the mean recovery for (d) and
(l) enantiomers of CA was shown in Table 4. The recovery
of internal standard (2000 ng/mL) was 96.35 %.
Accuracy and precision
The results of accuracy and precision throughout the
standard curve for (d) and (l) enantiomers of CA are
presented in Table 5. The RSD values of intra-day and
inter-day precision for two enantiomers were less than
4.2 %. All the values of accuracy and precision including
the LLOQ fell within the limits which were considered
as acceptable.
Stability studies
The concentrations of CA at low (300 ng/mL) and high
(5000 ng/mL) level samples deviated within ±15 % of the
nominal concentrations in stability tests like in-injector
(24 h), bench-top (12 h), three repeated freeze-thaw cy-
cles, and freezer stability (−80 ± 10 °C for 25 days)
(Table 6). The results were found to be within the assay
variability limits during the entire process.
Conclusions
The developed method was found to be sensitive,
specific, and robust for quantification of both the
(d) and (l) enantiomers of carbinoxamine in human
plasma. The method involved sample preparation
with adequate recovery by liquid-liquid extraction.
Method parameters like % alcoholic modifier, % basic
additive, and flow rate were successfully adjusted.
The method ensured as a robust one from the re-
sponses obtained. Even for injection volume 25 μL
the method is quite sensitive. The method is user-
friendly because of using green solvents n-Hexane
and ethanol. It is concluded that the method is suitable
for the routine quantification of (d) and (l) enantiomers of
CA in human plasma.
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